Prospective, Phase 3, Randomized, Multi-center, Double-blind Study of Efiicacy, Tolerability & Safety of Sulopenem & Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro-metronidazole for Treatment of cIAI in Adults
Latest Information Update: 02 Feb 2024
At a glance
- Drugs Sulopenem (Primary) ; Sulopenem (Primary) ; Sulopenem (Primary) ; Sulopenem (Primary) ; Amoxicillin/clavulanic acid; Ciprofloxacin; Ertapenem; Metronidazole
- Indications Intra-abdominal infections
- Focus Registrational; Therapeutic Use
- Acronyms SURE 3
- Sponsors Iterum Therapeutics
- 19 Jun 2023 Results (n=670) assessing beta-lactamase content of select Enterobacterales isolates recovered from patients enrolled in this trial presented at the ASM Microbe 2023
- 25 Apr 2022 According to an Iterum Therapeutics media release, data from the study was presented at the 32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
- 12 Nov 2021 According to an Iterum Therapeutics media release, the company has requested a Type B meeting with the FDA to discuss the design of a potential new clinical trial to support such potential resubmission.